Atlas Trials

Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).

Clinical trial NCT02556229 · COMPLETED

Trial details

NCT number
NCT02556229
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Inflammatory Choroidal Neovascularization
Start date
2016-06-01
Primary completion
2019-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.